Related Experiment Video
Updated: May 14, 2026

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines
Published on: November 9, 2020
Towards the targeted protein degradation of CK2: design and synthesis of CAM4066-based PROTACs
Sophie Day-Riley1, Sona Krajcovicova1,2, Aryaman Raj Sokhal1
1Yusuf Hamied Department of Chemistry, University of Cambridge, Lensfield Road, CB2 1EW, Cambridge, United Kingdom.
Abstract:
Human protein kinase CK2 is a constitutively active serine/threonine kinase implicated in numerous cancers. Although ATP-competitive inhibitors such as CX-4945 show therapeutic potential, they are limited by off-target effects and incomplete or transient CK2 suppression. PROTACs offer an alternative strategy by inducing proteasome-mediated degradation, with potential advantages in potency, selectivity, and duration of action. Herein, a series of CK2-targeting PROTACs has been designed and synthesised. By conjugating a CAM4066-derived warhead to CRBN or VHL ligands, four VHL-recruiting PROTACs, were prepared using PEG and alkyl linkers, alongside two CRBN-recruiting analogues featuring constrained linkers. A ligand-linker analogue in which a linker is projected from the solvent-exposed region of CK2α retained binding affinity comparable to CAM4066, confirming that linker installation is tolerated and preserves key interactions in the αD and ATP sites.
Insights
Researchers developed novel PROTACs to degrade human protein kinase CK2, a cancer target. These PROTACs offer potential for more effective and selective cancer therapy than traditional inhibitors.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Human protein kinase CK2 (CK2) is a serine/threonine kinase constitutively active in numerous cancers.
- Current ATP-competitive inhibitors like CX-4945 have limitations including off-target effects and incomplete CK2 suppression.
More Related Videos
07:22The Development and Application of Biophysical Assays for Evaluating Ternary Complex Formation Induced by Proteolysis Targeting Chimeras (PROTACS)
Published on: January 12, 2024
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
Related Concept Videos
cAMP-dependent Protein Kinase Pathways
Anaphase Promoting Complex
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
C4 Pathway and CAM
C4 Pathway
The C4 pathway is used by plants such as...
Positive Regulator Molecules